| |
|
|
|
Galectin Therapeutics Inc.  
|
|
3.86 0.12 (0.03%) |
06-18 16:00 |
|
Open: |
3.89 |
Pre close: |
3.74 |
Target:
|
5.17
|
|
High: |
3.9921 |
Low: |
3.75 |
Resistance:
|
4.43
4.97
|
|
Volume: |
176,536 |
Market Cap: |
216M |
Support:
|
3.55
2.95
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.72
 |
MACD |
MACD(12,26):
|
-0.19 |
|
MA(20): |
3.94  |
Signal(12,26,9): |
-0.20 |
|
MA(100): |
4.62 |
Stochastic Oscillator |
%K(14,3):
|
31.61 |
|
MA(250): |
4.95 |
%D(3): |
21.66 |
|
Average Volume(K) |
3-Month: |
37059
|
52-Week |
High:
|
9.00 |
|
10-Days: |
28429 |
Low: |
3.17 |
|
RSI |
RSI(14):
|
43.17 |
Change(%): |
-56.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.380 |
Return on Equity (ttm) |
3352.0 |
Shares Out. (M) |
55.99 |
|
EPS Est. Current Year |
-0.530 |
Return on Assets (ttm) |
-318.1 |
Shares Float (M) |
48.25 |
|
EPS Est. Next Year |
-0.520 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.130 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
16.30 |
|
Forward EPS |
-0.690 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
47.420 |
EBITDA (p.s.) |
0.000 |
P/E |
-10.16 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.08 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-9.95 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-5.09 |
P/CF |
-21.72 |
|
|
|
|
|
|
